ArticleOrphanet journal of rare diseases2015

Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy.

Daniela Miglietta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.